Selection of blockbuster announcements

1、$Li Auto Inc.-W (02015.HK) $Ideal L9 order exceeds 30,000 vehicles

Li Auto Inc.-W announced that since its intelligent flagship SUV ideal L9 was booked on June 24, 2022 (US Eastern time), the order has exceeded 30000 vehicles within 72 hours, demonstrating the excellent attractiveness of the ideal L9 to home users. The deposit of RMB 5000 for booking ideal L9 can be refunded within a limited time.

2、$Sino Biopharmaceutical (01177.HK) $The anti-tumor class 1 innovative drug "TQ-B3101 capsule" was accepted for listing.

Sino Biopharmaceutical announced that the anti-tumor class 1 innovative drug "TQ-B3101 capsule" developed by the group has been listed and accepted by the State Drug Administration of China. The indication of this declaration is ROS1 positive non-small cell lung cancer. TQ-B3101 capsule is the first kind of innovative drug recently declared and listed by the group after TQ-B3139. The Group has made continuous breakthroughs in the research and development of innovative drugs, and the new drug pipeline has gradually entered the harvest period.

3、$Xinyi Solar (00968.HK) $PCCW: it is expected that the consolidated net profit attributable to equity holders will decrease by 33% to 43% in the first half of the year.

Xinyi Solar announced that the group expects the consolidated net profit attributable to equity holders to fall by 33% to 43% in the first half of 2022, compared with about HK $3.072 billion in the same period last year. According to the announcement, the decrease in profit was mainly due to a 10-20% year-on-year drop in the average market price of the group's solar glass products in the first half of 2022, and a significant increase in raw materials and energy costs such as soda ash and natural gas. However, the impact of the above adverse factors was partly offset by the Group's high sales volume and increased production efficiency.

4、$Tianyu Real Estate (00059.HK) $HK $340 million loan and related interest not repaid when due

Tianyu Real Estate notice that the company has a mortgage loan with a financial institution in Hong Kong (the "lender") with an outstanding principal of HK $340 million. As the lender finally failed to approve the extension of the loan after the grace period, all outstanding principal together with interest on the loan is now due and payable, and the company is unable to repay the outstanding principal and accrued interest immediately. As of the date of the announcement, the lender has not taken any compulsory action.

5、$INNOVENT BIO (01801.HK) $NMPA approved Dabeshu as a new indication for first-line treatment of gastric and gastroesophageal junction adenocarcinoma

INNOVENT BIO announced that the State Drug Administration (NMPA) has formally approved the innovative drug PD-1 inhibitor Dabeshu (Xindizumab injection) combined with fluorouracil and platinum chemotherapy for unresectable locally advanced, recurrent or metastatic gastric and gastroesophageal junction adenocarcinoma. application for new indications for first-line treatment.

6、China Vocational Education (01756.HK) $Guangzhou Huali College 2022 University2023 year General College enrollment increased significantly

China vocational education announced that the number of general college enrollment places in Guangzhou Huali College, a company's undergraduate college, increased significantly in the 2023 academic year, and the number of general college enrollment places was 4637, an increase of 199.7% over the same period last year.

7、$Yidu Technology (02158.HK) $Announced annual results, revenue from life science solutions increased by 95%

According to the announcement of Yidu Science and Technology, for the financial year ended March 31, 2022, the company's revenue was 1.237 billion yuan (the same as the unit below), an increase of 42.7% over the same period last year. Revenue from big data platform and solutions increased by 10.7% from RMB 402 million for the financial year ended March 31, 2021 to RMB 445 million for the year ended March 31, 2021, mainly due to an increase in the number of active customers. As of March 31, 2022, the company provided solutions to 82 Chinese head research hospitals, 26 regulators and policy makers, adding 6 hospitals and 7 regulators and policy makers respectively during the reporting period. The number of customers of life science solutions served by the Group reached 141 as of March 31, 2022, an increase of 33 from 108 as of March 31, 2021. The number of active users who completed at least one transaction on the health management platform reached 12 million, more than double the number of about 5 million users as of March 31, 2021.

Listing of new shares

Shandong Merchant Service (02376) will issue shares from June 27 to 30 with a plan to issue 33.34 million shares.

Runmaide-B (02297), a medical device company, will issue 23.348 million shares from June 27 to 30.

Bowei Wisdom is the leader of IT solutions in Macau through the hearing of the Hong Kong Stock Exchange.

Growatt Technology HKEx, the world's largest provider of household photovoltaic inverters

Important matters

Li Auto Inc.-W (02015): ideal L9 order exceeds 30, 000 vehicles

Sino Biopharmaceutical (01177): anti-tumor class 1 innovative drug "TQ-B3101 capsule" declared and listed on the market

INNOVENT BIO (01801): NMPA approved Dabeshu as a new indication for first-line treatment of gastric and gastroesophageal junction adenocarcinoma

Country Garden Holdings (02007): bill offer settlement was completed on June 24th.

Tianyu Real Estate (00059): HK $340 million loan and related interest outstanding when due

Vocational Education in China (01756): the enrollment of general junior college students in Guangzhou Huali College has increased significantly in the 2022 / 2023 academic year.

Financial data

Yidu Technology (02158): revenue increased by 42.7% year-on-year to RMB 1.237 billion, and gross profit increased by 22.0% to RMB 399 million

China Gas (00384) announced annual results: revenue increased by 26.1% to HK $88.225 billion, with a final interest of HK $0.45 per share

The annual income of Zhiqin Holdings (09913) increased by about 90.6% year-on-year to HK $1.574 billion.

The annual revenue of Sibo system (08319) increased by about 27.8% to HK $682 million

Jinlun Holdings Limited (01783) earned an annual income of about HK $590 million, an increase of 180.9% over the same period last year.

Yucai Securities Finance (01428) annual profit fell 20.2% to HK $562 million, with a final interest rate of HK10 cents.

The comprehensive net profit of China Xinlianxin Chemical Fertilizer (01866) in the first quarter was about 520 million yuan, an increase of 88% over the same period last year.

The annual net profit of Security Engineering Holdings (01627) was HK $123 million, an increase of 29.76% over the same period last year.

The annual net profit of Superior 360 (02360) increased by 34.8% to HK $110 million, with a final interest of HK8 cents.

Wancheng Global Holdings (08309) released its annual results, showing a 92% drop in profit attributable to owners of HK $2.253 million compared with the same period last year.

Cuihua Holdings (01314) released its full-year results, with a loss of HK $118 million attributable to shareholders, which was 4.7% lower than the same period last year.

Dachang Micro Line Group (00567) released its full-year results with a loss of HK $29.128 million, which was 56.5% lower than the same period last year.

Jundong Holdings (08277) released its annual results, with a loss attributable to shareholders of HK $5.04 million, which was 81.67% lower than the same period last year.

Longhua International Group (08026) reported a loss of HK $37.32 million attributable to owners, which was 9% lower than the same period last year.

Performance forecast

Lutheran Glass (00868) expects its first-half net profit to be about HK $3.5 billion-2.69 billion, down 35% from the same period last year.

Kexuan Power Holdings (00476): estimated annual net loss narrowed to HK $394 million-436 million

Zhongpan Holdings (00715) profit warning: the net loss attributable to shareholders is expected to increase year-on-year in the medium term.

Xinyi Solar (00968) earnings Forecast: it is expected that the net profit in the first half of the year will decrease by about 33% and 43% compared with the same period last year.

Weijun Group Holdings (01013) earnings Police: expected annual consolidated net loss of not less than HK $100m

Investment and operation

Jinhui Holdings (09993) May contract sales value of about 3.91 billion yuan

The wholly-owned subsidiary of China Merchants International Ocean Holdings (00206), China Merchants hydrogen Technology (Qingdao) Co., Ltd., entered into a share transfer agreement with Shanghai Zhi hydrogen Enterprise Management Center.

Resume trading and suspend trading

Lotto Entertainment (08198): controlling shareholder or sale of company shares, resumption of trading on the 27th

Increase and decrease holdings

Zhongji Longevity Science (00767): controlling shareholder Yan Li sells 346.88 million shares of the company

Greentown Management Holdings (09979) receives 508000 shares from Chief Executive Officer and Executive Director Li Jun

Shi Chunbao, executive director and controlling shareholder of Chunli Medical (01858), increased his holding of 133800 H shares.

Merger and acquisition and sale

Cinda International Holdings (00111) plans to sell 35% stake in Jianxin International Trade.

Energy International Investment (00353) plans to purchase 8.50% voting rights of Shundong Port in Shandong Province with 86 million yuan.

Additional rights issue

Tibet Water Resources (01115) plans to issue shares at a discount of 9.57%, raising up to HK $220 million.

Zhaoyan New Drug (06127) will issue capitalized shares on the basis of 4 shares for every 10 shares.

Investment and operation

Haichang Ocean Park (02255) is approved by Shanghai Xinchuanhua to carry out the "Aut Energy Station" project.

China Broadcasting Holdings (00471) signed a quadripartite memorandum to set up a joint venture to operate the Smart City Internet of things and vehicle Internet of things project.

Silk Road Energy (08250) and China Reserve enter into a strategic cooperation agreement focusing on the trade, logistics, warehousing and supply of agricultural commodities.

First Bank Holdings (01703) and Jiesheng Holdings (Shenzhen) enter into a strategic cooperation agreement.

Chunli Medical (01858) received medical device registration certificates for 6 products.

Repurchase cancellation

AIA Group Limited (01299) spent HK $163 million to buy back 2.03 million shares on June 24th

HSBC Holdings PLC (00005) spent HK $81.1552 million to buy back 1.5884 million shares on June 23rd

China Vanke (02202) spent 51.7979 million yuan to buy back 2.8353 million A shares on June 24th.

ESR Cayman Limited (01821) spent HK $12.0706 million to buy back 600000 shares on June 24th

Zhihu Inc.-W (02390) announced that the company bought back 1500 shares at a price of HK $29.9 to HK $30 per share, at a cost of HK $45000.

Equity incentive

BeiGene, Ltd. (06160) granted options for 858000 American depositary shares

Reputation Stanley Feng Holdings (02132) granted a total of 8.56 million award shares

Yao Ming Juno-B (02126) granted 2.2824 million share options and 1.7036 million restricted shares

Hua Medicine-B (02552) granted 1 million share options

Tengsheng Bo Pharmaceutical-B (02137) granted 2.376 million share options and 981000 restricted shares

Personnel change

Guangdong Harbour Holdings (01396) appoints any Fei as executive director and president